Replies to post #215476 on Biotech Values

[DewDiligence]

PPHM -18%/AH on weak FY2Q18 revenue:

https://globenewswire.com/news-release/2017/12/11/1251063/0/en/Peregrine-Pharmaceuticals-Reports-Financial-Results-for-Second-Quarter-of-Fiscal-Year-2018-and-Recent-Developments.html

PPHM is no longer a drug-development company (not that it ever was in any serious sense), but rather is a money-losing contract manufacturing organization (CMO). The corporate name will become Avid Bioservices in January.